Proceedings of the American Association of Oral and Maxillofacial Surgeons 2015 Research Summit
Tài liệu tham khảo
Zizelmann, 2007, Computer-assisted reconstruction of orbital floor based on cone beam tomography, Br J Oral Maxillofac Surg, 45, 79, 10.1016/j.bjoms.2005.06.031
Metzger, 2007, Verification of clinical precision after computer-aided reconstruction in craniomaxillofacial surgery, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, e1, 10.1016/j.tripleo.2007.04.015
Essig, 2013, Precision of posttraumatic primary orbital reconstruction using individually bent titanium mesh with and without navigation: A retrospective study, Head Face Med, 9, 18, 10.1186/1746-160X-9-18
Petzold, 1999, Rapid prototyping technology in medicine—Basics and applications, Comput Med Imaging Graph, 23, 277, 10.1016/S0895-6111(99)00025-7
Ciocca, 2011, Direct metal laser sintering (DMLS) of a customized titanium mesh for prosthetically guided bone regeneration of atrophic maxillary arches, Med Biol Eng Comput, 49, 1347, 10.1007/s11517-011-0813-4
Mazzoli, 2013, Selective laser sintering in biomedical engineering, Med Biol Eng Comput, 51, 245, 10.1007/s11517-012-1001-x
Sharifi, 2008, How accurate is model planning for orthognathic surgery?, Int J Oral Maxillofac Surg, 37, 1089, 10.1016/j.ijom.2008.06.011
Bailey, 1981, Accuracy of Frankfort plane transfer of the Hanau articulator, J Dent Res, 60, 531
Ellis, 1992, Accuracy of face-bow transfer: Effect on surgical prediction and postsurgical result, J Oral Maxillofac Surg, 50, 562, 10.1016/0278-2391(92)90434-2
Farrell, 2009, Safe, efficient, and cost-effective orthognathic surgery in the outpatient setting, J Oral Maxillofac Surg, 67, 2064, 10.1016/j.joms.2009.04.096
Morrison, 2015, Mitigation of tracheobronchomalacia with 3D-printed personalized medical devices in pediatric patients, Sci Transl Med, 7, 285, 10.1126/scitranslmed.3010825
Hankenson, 2014, Biological perspectives of delayed fracture healing, Injury, 45, S8, 10.1016/j.injury.2014.04.003
Lu, 2011, Mechanical stability affects angiogenesis during early fracture healing, J Orthop Trauma, 25, 494, 10.1097/BOT.0b013e31822511e0
Bahney, 2014, Stem cell-derived endochondral cartilage stimulates bone healing by tissue transformation, J Bone Miner Res, 29, 1269, 10.1002/jbmr.2148
Izumi, 2013, Intraoral grafting of tissue-engineered human oral mucosa, Int J Oral Maxillofac Implants, 28, e295, 10.11607/jomi.te11
Kato, 2015, Fabrication of large size ex vivo-produced oral mucosal equivalents for clinical application, Tissue Eng Part C Methods, 21, 872, 10.1089/ten.tec.2014.0600
Kuo, 2015, Biochemical indicators of implantation success of tissue-engineered oral mucosa, J Dent Res, 94, 78, 10.1177/0022034514554225
Khmaladze, 2015, Human oral mucosa tissue-engineered constructs monitored by Raman fiber-optic probe, Tissue Eng Part C Methods, 21, 46, 10.1089/ten.tec.2013.0622
Peramo, 2012, Tissue engineering of lips and muco-cutaneous junctions: In vitro development of tissue engineered constructs of oral mucosa and skin for lip reconstruction, Tissue Eng Part C Methods, 18, 273, 10.1089/ten.tec.2011.0406
Herford, 2008, Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2), J Oral Maxillofac Surg, 66, 616, 10.1016/j.joms.2007.11.021
Kolokythas, 2010, Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: Is there an association with perineural invasion?, J Oral Maxillofac Surg, 68, 1290, 10.1016/j.joms.2010.01.006
Ye, 2011, Nerve growth factor links oral cancer progression, pain, and cachexia, Mol Cancer Ther, 10, 1667, 10.1158/1535-7163.MCT-11-0123
Kumar, 2015, Conservative surgical approach to aggressive benign odontogenic neoplasm: A report of three cases, J Korean Assoc Oral Maxillofac Surg, 41, 37, 10.5125/jkaoms.2015.41.1.37
Hasegawa, 2013, Retrospective study of ameloblastoma: The possibility of conservative treatment, Kobe J Med Sci, 59, E112
Hammarfjord, 2013, Surgical treatment of recurring ameloblastoma, are there options?, Br J Oral Maxillofac Surg, 51, 762, 10.1016/j.bjoms.2013.08.013
Carlson, 2006, The ameloblastoma: Primary, curative surgical management, J Oral Maxillofac Surg, 64, 484, 10.1016/j.joms.2005.11.032
Marx, 1993, Swelling of the retromolar region and cheek associated with limited opening, J Oral Maxillofac Surg, 51, 304, 10.1016/S0278-2391(10)80180-6
2005
Gailey, 2014, Depth of penetration of methylene blue in mandibular cortical bone, Oral Surg Oral Med Oral Pathol Oral Radiol, 117, e246, 10.1016/j.oooo.2012.04.029
Iwai, 2011, Use of methylene blue for precise peripheral ostectomy of keratocystic odontogenic tumour, Br J Oral Maxillofac Surg, 49, e84, 10.1016/j.bjoms.2011.02.008
Schmidt, 2001, The use of enucleation and liquid nitrogen cryotherapy in the management of odontogenic keratocysts, J Oral Maxillofac Surg, 59, 720, 10.1053/joms.2001.24278
Schmidt, 2004, Neurosensory changes after liquid nitrogen cryotherapy, J Oral Maxillofac Surg, 62, 1183, 10.1016/j.joms.2004.03.012
Thesleff, 2003, Epithelial-mesenchymal signalling regulating tooth morphogenesis, J Cell Sci, 116, 1647, 10.1242/jcs.00410
Athar, 2014, Sonic hedgehog signaling in basal cell nevus syndrome, Cancer Res, 74, 4967, 10.1158/0008-5472.CAN-14-1666
Ally, 2014, The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome, JAMA Dermatol, 150, 542, 10.1001/jamadermatol.2013.7444
Happle, 1986, The McCune-Albright syndrome: A lethal gene surviving by mosaicism, Clin Genet, 29, 321, 10.1111/j.1399-0004.1986.tb01261.x
Chapurlat, 2012, Pathophysiology and medical treatment of pain in fibrous dysplasia of bone, Orphanet J Rare Dis, 24, S3, 10.1186/1750-1172-7-S1-S3
Rieger, 1994, Melanotic macules following Blaschko’s lines in McCune-Albright syndrome, Br J Dermatol, 130, 215, 10.1111/j.1365-2133.1994.tb02903.x
Boyce, 2015, Fibrous dysplasia/McCune-Albright syndrome, 1993
Weinstein, 1991, Activating mutations of the stimulatory G protein in the McCune-Albright syndrome, N Engl J Med, 325, 1688, 10.1056/NEJM199112123252403
Boyce, 2012, Denosumab treatment for fibrous dysplasia, J Bone Miner Res, 27, 1462, 10.1002/jbmr.1603
Chapurlat, 2004, Treatment of fibrous dysplasia of bone with intravenous pamidronate: Long-term effectiveness and evaluation of predictors of response to treatment, Bone, 35, 235, 10.1016/j.bone.2004.03.004
Auclair, 1988, A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor, Oral Surg Oral Med Oral Pathol, 66, 197, 10.1016/0030-4220(88)90094-1
Bataineh, 2002, The surgical treatment of central giant cell granuloma of the mandible, J Oral Maxillofac Surg, 60, 756, 10.1053/joms.2002.33241
Troulis, 2004, Staged protocol for resection, skeletal reconstruction, and oral rehabilitation of children with jaw tumors, J Oral Maxillofac Surg, 62, 335, 10.1016/j.joms.2003.07.006
Webb, 1986, Combined curettage and cryosurgical treatment for the aggressive “giant cell lesion” of the mandible, Int J Oral Maxillofac Surg, 15, 780, 10.1016/S0300-9785(86)80124-7
Suárez-Roa Mde, 2009, Interventions for central giant cell granuloma (CGCG) of the jaws, Cochrane Database Syst Rev, 4, CD007404
Ferretti, 2011, Management of central giant cell granuloma of mandible using intralesional corticosteroids: Case report and review of literature, J Oral Maxillofac Surg, 69, 2824, 10.1016/j.joms.2010.11.020
Yanik, 2013, Management of central giant cell granuloma of mandible using intralesional corticosteroids: Case report and review of literature, J Oral Maxillofac Surg, 71, 721, 10.1016/j.joms.2012.10.013
Allon, 2009, Central giant cell lesion of the jaw: Nonsurgical treatment with calcitonin nasal spray, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, 811, 10.1016/j.tripleo.2009.02.013
Vered, 2007, Calcitonin nasal spray for treatment of central giant cell granuloma: Clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, 226, 10.1016/j.tripleo.2006.05.020
Kaban, 2002, Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws, J Oral Maxillofac Surg, 60, 1103, 10.1053/joms.2002.34975
de Lange, 2007, Central giant cell granuloma of the jaw: A review of the literature with emphasis on therapy options, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, 603, 10.1016/j.tripleo.2007.04.003
Schreuder, 2014, Alternative pharmacologic therapy for aggressive central giant cell granuloma: Denosumab, J Oral Maxillofac Surg, 72, 1301, 10.1016/j.joms.2014.02.017
Naidu, 2014, Management of central giant cell granuloma with subcutaneous denosumab therapy, J Oral Maxillofac Surg, 72, 2469, 10.1016/j.joms.2014.06.456
Thomas, 2010, Denosumab in patients with giant-cell tumour of bone: An open-label, phase 2 study, Lancet Oncol, 11, 275, 10.1016/S1470-2045(10)70010-3
Huang, 2000, Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant-cell tumor of the bone: Possible involvement in tumor cell induced osteoclast-like cell formation, Am J Pathol, 156, 761, 10.1016/S0002-9440(10)64942-5
Thomas, 2009, Giant cell tumour of bone, Curr Opin Oncol, 21, 338, 10.1097/CCO.0b013e32832c951d
Stadler, 2015, A recurrent giant cell tumor of bone treated with denosumab, Clin Pract, 5, 697, 10.4081/cp.2015.697
Kurppa, 2014, High frequency of BRAF V600E mutations in ameloblastoma, J Pathol, 232, 492, 10.1002/path.4317
Sweeney, 2014, Identification of recurrent SMO and BRAF mutations in ameloblastomas, Nat Genet, 46, 722, 10.1038/ng.2986
Brown, 2014, Activating FGFR2-RAS-BRAF mutations in ameloblastoma, Clin Cancer Res, 20, 5517, 10.1158/1078-0432.CCR-14-1069
Gomes, 2014, Progress towards personalized medicine for ameloblastoma, J Pathol, 232, 488, 10.1002/path.4331
Resnick, 2010, Maxillofacial and axial/appendicular giant cell lesions: Unique tumors or variants of the same disease?—A comparison of phenotypic, clinical, and radiographic characteristics, J Oral Maxillofac Surg, 68, 130, 10.1016/j.joms.2009.04.106
Peacock, 2012, Do histologic criteria predict biologic behavior of giant cell lesions?, J Oral Maxillofac Surg, 70, 2573, 10.1016/j.joms.2011.12.005
Peacock, 2014, Genetic analysis of giant cell tumors of the axial/appendicular and maxillofacial skeleton J, Am Coll Surg, 219, S70, 10.1016/j.jamcollsurg.2014.07.163